These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 18849414)

  • 1. The structural impact of a polyglutamine tract is location-dependent.
    Robertson AL; Horne J; Ellisdon AM; Thomas B; Scanlon MJ; Bottomley SP
    Biophys J; 2008 Dec; 95(12):5922-30. PubMed ID: 18849414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-domain misfolding: understanding the aggregation pathway of polyglutamine proteins.
    Saunders HM; Bottomley SP
    Protein Eng Des Sel; 2009 Aug; 22(8):447-51. PubMed ID: 19589877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rate of polyQ-mediated aggregation is dramatically affected by the number and location of surrounding domains.
    Robertson AL; Bate MA; Buckle AM; Bottomley SP
    J Mol Biol; 2011 Nov; 413(4):879-87. PubMed ID: 21945530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyglutamine expansion mutation yields a pathological epitope linked to nucleation of protein aggregate: determinant of Huntington's disease onset.
    Sugaya K; Matsubara S; Kagamihara Y; Kawata A; Hayashi H
    PLoS One; 2007 Jul; 2(7):e635. PubMed ID: 17653262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mimicking proteasomal release of polyglutamine peptides initiates aggregation and toxicity.
    Raspe M; Gillis J; Krol H; Krom S; Bosch K; van Veen H; Reits E
    J Cell Sci; 2009 Sep; 122(Pt 18):3262-71. PubMed ID: 19690053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of the toxic conformation of the expanded polyglutamine stretch leads to suppression of aggregate formation and cytotoxicity.
    Popiel HA; Nagai Y; Onodera O; Inui T; Fujikake N; Urade Y; Strittmatter WJ; Burke JR; Ichikawa A; Toda T
    Biochem Biophys Res Commun; 2004 May; 317(4):1200-6. PubMed ID: 15094397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analyzing the aggregation of polyglutamine-expansion proteins and its modulation by molecular chaperones.
    Kubota H; Kitamura A; Nagata K
    Methods; 2011 Mar; 53(3):267-74. PubMed ID: 21195182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyglutamine homopolymers having 8-45 residues form slablike beta-crystallite assemblies.
    Sharma D; Shinchuk LM; Inouye H; Wetzel R; Kirschner DA
    Proteins; 2005 Nov; 61(2):398-411. PubMed ID: 16114051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity.
    Sakahira H; Breuer P; Hayer-Hartl MK; Hartl FU
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16412-8. PubMed ID: 12189209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folding of polyglutamine chains.
    Chopra M; Reddy AS; Abbott NL; de Pablo JJ
    J Chem Phys; 2008 Oct; 129(13):135102. PubMed ID: 19045125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyglutamine induced misfolding of huntingtin exon1 is modulated by the flanking sequences.
    Lakhani VV; Ding F; Dokholyan NV
    PLoS Comput Biol; 2010 Apr; 6(4):e1000772. PubMed ID: 20442863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards the treatment of polyglutamine diseases: the modulatory role of protein context.
    Robertson AL; Bottomley SP
    Curr Med Chem; 2010; 17(27):3058-68. PubMed ID: 20629626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chaperonin TRiC promotes the assembly of polyQ expansion proteins into nontoxic oligomers.
    Behrends C; Langer CA; Boteva R; Böttcher UM; Stemp MJ; Schaffar G; Rao BV; Giese A; Kretzschmar H; Siegers K; Hartl FU
    Mol Cell; 2006 Sep; 23(6):887-97. PubMed ID: 16973440
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monitoring polyglutamine toxicity in yeast.
    Duennwald ML
    Methods; 2011 Mar; 53(3):232-7. PubMed ID: 21144902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A toxic monomeric conformer of the polyglutamine protein.
    Nagai Y; Inui T; Popiel HA; Fujikake N; Hasegawa K; Urade Y; Goto Y; Naiki H; Toda T
    Nat Struct Mol Biol; 2007 Apr; 14(4):332-40. PubMed ID: 17369839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanism of binding staphylococcal protein A to immunoglobin G does not involve helix unwinding.
    Jendeberg L; Tashiro M; Tejero R; Lyons BA; Uhlén M; Montelione GT; Nilsson B
    Biochemistry; 1996 Jan; 35(1):22-31. PubMed ID: 8555177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of chain length on the aggregation of model polyglutamine peptides: molecular dynamics simulations.
    Marchut AJ; Hall CK
    Proteins; 2007 Jan; 66(1):96-109. PubMed ID: 17068817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PolyQ fibrillation in the cell nucleus: who's bad?
    von Mikecz A
    Trends Cell Biol; 2009 Dec; 19(12):685-91. PubMed ID: 19796946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous formation of polyglutamine nanotubes with molecular dynamics simulations.
    Laghaei R; Mousseau N
    J Chem Phys; 2010 Apr; 132(16):165102. PubMed ID: 20441310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-terminal polyglutamine-containing fragments inhibit androgen receptor transactivation function.
    Schiffer NW; Céraline J; Hartl FU; Broadley SA
    Biol Chem; 2008 Dec; 389(12):1455-66. PubMed ID: 18844449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.